People need to comprehend the trade off
We potentially exchanged our iminant insomnia and opiod outcomes ... for what right?
That's the question we just halved our iminant position about to yeild for what?
Ilera exec team took nothing to 125ml in US with one drug in one state
They have right to take this drug into every state
The drug is at market and capable of producing revenues NOW
Zelda has yet to be validated insomnia and opiod drugs and no money left in the bank
Zeleria now has this prooven and motivated team taking multiple products accross every state in the US
The cost to set up our own teams in the us for insomnia autism and opiod would have been beyond us.
we have a deal that now transforms zelira into an established revenue business accross multiple products in the US
Ann: Zelda to merge with US-based Ilera Therapeutics, page-48
-
- There are more pages in this discussion • 267 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
